As a result, imperfect dosing can lead to a state of relative hyperinsulinemia (i.e., excess systemic insulin levels relative to blood glucose concentration), in which glucose counterregulatory mechanisms become critical to protecting against hypoglycemia (Rahier et al., 1983). This evidence concerns the gene INS and Hypoglycemia.